Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development
Summary: Novel therapeutics to manage PCA bacterial infections are urgently needed as the impact and prevalence of antimicrobial resistance (AMR) grows.Antivirulence therapeutics are an alternative approach to antibiotics that aim to attenuate virulence rather than target bacterial essential functions, while minimizing microbiota perturbation and t